Advances in metabolomics, proteomics and genomics caused great excitement in anticipation for their potential use in toxicological investigations and risk assessments. Toxicologists were some of the first to demonstrate the utility of the novel analytical and DNA analysis techniques in experimental health sciences. More than a decade on how or have these technologies helped us towards more secure risks assessments?
The meeting will include the presentation of the 2017 RSC Toxicology Award to Professor Andy Smith, MRC Toxicology Unit.
Early bird rates - £90 RSC / £120 non-members. Special rate available for IGHRC members.
Confirmed speakers:
Andy Smith, MRC Toxicology Unit – The changing ‘omics’ landscape
Tim Gant, Public Health England - Toxicogenomics, human risk assessment and possible regulatory uses
Muireann Coen, Imperial College London / AstraZeneca - Human early life exposome (HELIX) and omics
Andy White, SETAC, Unilever – Application and use of ‘omic’ data for next generation risk assessment
Mark Viant, Phenome Centre, University of Birmingham – Accelerating the impacts of metabolomics in regulatory toxicology
George Loizou, HSE’s Health & Safety Laboratory – Metabolomics in regulatory toxicology?
Marion MacFarlane, MRC Toxicology Unit – Are long carbon nanotubes the new asbestos; genomic evidence?
The meeting will include the presentation of the 2017 RSC Toxicology Award to Professor Andy Smith, MRC Toxicology Unit.
Early bird rates - £90 RSC / £120 non-members. Special rate available for IGHRC members.
Confirmed speakers:
Andy Smith, MRC Toxicology Unit – The changing ‘omics’ landscape
Tim Gant, Public Health England - Toxicogenomics, human risk assessment and possible regulatory uses
Muireann Coen, Imperial College London / AstraZeneca - Human early life exposome (HELIX) and omics
Andy White, SETAC, Unilever – Application and use of ‘omic’ data for next generation risk assessment
Mark Viant, Phenome Centre, University of Birmingham – Accelerating the impacts of metabolomics in regulatory toxicology
George Loizou, HSE’s Health & Safety Laboratory – Metabolomics in regulatory toxicology?
Marion MacFarlane, MRC Toxicology Unit – Are long carbon nanotubes the new asbestos; genomic evidence?
